The study suggests that the natural product like compound STOCK1N-86169, which presents a new scaffold for Mpro inhibition and also SARS-CoV-2, may be a promising candidate for further development as an effective inhibitor of SARS-CoV-2 Mpro.
It is revealed that the S2 binding site serves as a key region to anchor most non-covalent inhibitors of SARS-CoV-2 Mpro, which is a promising target for coronavirus disease 2019 (COVID-19) therapy.
Aunlika Chimprasit, G. Bret, S. Hannongbua et al.· Journal of Computer-Aided Mo...· 0 citations
The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.
Mohd Yasir Khan, Farah Maarfi, A. Shah et al.· International Journal of Mol...· 0 citations
Overall, vitexin shows promising binding characteristics as a natural compound targeting Mpro, but it does not surpass the native ligand in terms of overall binding stability, warranting further optimization and experimental validation.
Syahida Djasang, Artati Artati· Journal of the Turkish Chemi...· 0 citations
The phenoxypropanol (PP) and bipiperidine (BPP) series stood out as the most promising SARS-CoV-2 antivirals, with integrated analysis of structure–activity relationships, physicochemical parameters, metabolic stability, and interdomain dynamics delineated structural optimization paths for both series.
Alma C. Castañeda-Leautaud, Thomas D. Bannister, Eunjung Kim et al.· Chemical Science· 0 citations
Abstract A new series of thiazole-based carboxamide derivatives (5–12) was designed, synthesized with structural elucidation performed using standard spectroscopic techniques including NMR and HRMS. The synthesized compounds were evaluated for their inhibitory activity against SARS-CoV-2 papain-like protease (PLpro) an...
Imran Khan, Rafaqat Hussain, Hina Sarfraz et al.· Zeitschrift für Naturforschu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.